These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6365273)

  • 1. Pharmacology of intraperitoneal chemotherapy.
    Myers CE; Collins JM
    Cancer Invest; 1983; 1(5):395-407. PubMed ID: 6365273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of intraperitoneal chemotherapy in the treatment of ovarian cancer.
    Myers C
    Semin Oncol; 1984 Sep; 11(3):275-84. PubMed ID: 6385257
    [No Abstract]   [Full Text] [Related]  

  • 3. [A randomized clinical trial of cyclophosphamide versus adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate in advanced ovarian carcinoma--a preliminary report ].
    Chylak V; Ilijas M; Krusić J; Kolarić K
    Lijec Vjesn; 1982; 104(3-4):120-2. PubMed ID: 6750298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraperitoneal chemotherapy: a review.
    Brenner DE
    J Clin Oncol; 1986 Jul; 4(7):1135-47. PubMed ID: 3522820
    [No Abstract]   [Full Text] [Related]  

  • 6. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
    Myers CE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraperitoneal contrast infusion for assessment of intraperitoneal fluid dynamics.
    Dunnick NR; Jones RB; Doppman JL; Speyer J; Myers CE
    AJR Am J Roentgenol; 1979 Aug; 133(2):221-3. PubMed ID: 110083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlled prospective trial of combination chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil for the treatment of advanced ovarian cancer: a preliminary report.
    Bruckner HW; Pagano M; Falkson G; Creech R; Arseneau JC; Horton J; Brodovsky H; Davis TE; Slayton RW; Greenspan E
    Cancer Treat Rep; 1979 Feb; 63(2):297-9. PubMed ID: 376136
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison of the results of single-drug and combination chemotherapy of advanced ovarian cancer after 1 year].
    Sablińska B; Cześnin K; Ploch E
    Ginekol Pol; 1979 Jun; 50(6):501-5. PubMed ID: 478338
    [No Abstract]   [Full Text] [Related]  

  • 10. Intraperitoneal chemotherapy for advanced ovarian cancer.
    Lucas WE; Markman M; Howell SB
    Am J Obstet Gynecol; 1985 Jun; 152(4):474-8. PubMed ID: 3925784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexamethylmelamine-CAF (cyclophosphamide, methotrexate, and 5-FU) and cisplatin-CAF in refractory ovarian cancer.
    Sessa C; D'Incalci M; Valente I; Bolis G; Colombo N; Mangioni C
    Cancer Treat Rep; 1982 May; 66(5):1233-4. PubMed ID: 6805951
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer.
    Miller AB; Klaassen DJ; Boyes DA; Dodds DJ; Gerulath A; Kirk ME; Levitt M; Pearson JG; Wall C
    Can Med Assoc J; 1980 Sep; 123(5):365-71. PubMed ID: 7020903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evaluation of anticancer drugs against ovarian cancer at concentrations achievable by intraperitoneal administration.
    Alberts DS; Young L; Mason N; Salmon SE
    Semin Oncol; 1985 Sep; 12(3 Suppl 4):38-42. PubMed ID: 3931226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO III and IV) as measured by surgical end-staging (second-look surgery)--the mount sinai experience.
    Cohen CJ; Bruckner HW; Goldberg JD; Holland JF
    Clin Obstet Gynaecol; 1983 Aug; 10(2):307-24. PubMed ID: 6413114
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy in advanced ovarian carcinoma: current standards of care based on randomized trials.
    Thigpen T; Vance R; Puneky L; Khansur T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S97-107. PubMed ID: 7835816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of ovarian cancer.
    Ozols RF; Young RC
    Semin Oncol; 1984 Sep; 11(3):251-63. PubMed ID: 6435250
    [No Abstract]   [Full Text] [Related]  

  • 17. The case for combination chemotherapy in the treatment of advanced ovarian cancer.
    Ozols RF
    J Clin Oncol; 1985 Nov; 3(11):1445-7. PubMed ID: 3932603
    [No Abstract]   [Full Text] [Related]  

  • 18. Hexamethylmelamine, methotrexate and 5-fluorouracil (HMF) for progressive ovarian carcinoma during therapy with cis-platinum, cyclophosphamide +/- doxorubicin.
    Carlson JA; Day TG; Botts B; Masterson BJ
    Gynecol Oncol; 1985 Oct; 22(2):189-94. PubMed ID: 3932141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human ovarian cancer colony formation: growth from malignant washings and pharmacologic applications.
    Ozols RF; Willson JK; Young RC
    Prog Clin Biol Res; 1980; 48():247-57. PubMed ID: 7208519
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination chemotherapy in advanced breast cancer. A report of the Working Party of the Multicentre Cancer Chemotherapy Group.
    Spittle MF; Bates TD; Kitchen G; Nicol NT; Wheeler T; Edelstyn G; MacRae KD; Ostrowski MJ
    Clin Oncol; 1980 Jun; 6(2):153-7. PubMed ID: 7408282
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.